Collectively, these data suggest alteration of the signaling pathways and biological functions identified in the emerin-null cells may be responsible for the impaired differentiation and regeneration seen in EDMD patients. The gene discussed is EMD; the disease is Emery-Dreifuss muscular dystrophy.